Active ingredientVincristineCat. No. P-V047-001CAS 57-22-7Family · Pharmaceutical analytical standards
Vincristine
An alkaloid of the Madagascar periwinkle (Catharanthus roseus), isolated in 1961 and approved in the United States in 1963; it blocks cell division and is used against acute lymphoblastic leukaemia, lymphomas and Wilms tumour. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?The periwinkle alkaloids were discovered while studying the plant, used in infusions as a folk remedy for diabetes: in animals the extracts did not lower blood sugar but made white blood cell counts plummet.
Go to the active ingredient →Active ingredientVincristineCat. No. P-V047-001CAS 57-22-7
Pharmacopoeial impurityVincristine EP Impurity BCat. No. P-V047-002CAS 68135-16-0
Pharmacopoeial impurityVincristine EP Impurity CCat. No. P-V047-003CAS 18172-50-4
Pharmacopoeial impurityVincristine EP Impurity DCat. No. P-V047-004CAS 3704-01-6
Pharmacopoeial impurityVincristine EP Impurity FCat. No. P-V047-005
Isotopically labelledVincristine-d3Cat. No. P-V047-006CAS 1246817-09-3
ImpurityVincristine Impurity 1Cat. No. P-V047-007
ImpurityVincristine Impurity 2Cat. No. P-V047-008CAS 910580-56-2
ImpurityVincristine Impurity GCat. No. P-V047-011
ImpurityVincristine Impurity KCat. No. P-V047-014
Active ingredientVincristine SulfateCat. No. P-V047-017CAS 2068-78-2No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceVincristine sulfate CRSEDQM code V0400000Family VincristineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.